Mo:re
Focus: Mo:re develops 3D cell culture robotics technology for biotech research and drug development, headquartered in Hamburg, Germany. The company operates in the biotechnology instrumentation segment with a focus on psychiatry applications.
Profile data last refreshed 14h ago · AI intelligence enriched 3w ago
Open Jobs
3
Should You Work at Mo:re?
AI assessmentMo:re is a high-risk, high-reward early-stage biotech play best suited for entrepreneurial scientists comfortable with uncertainty but attracted by the chance to own a emerging automation platform.
Why Work Here
- Join an early-stage deep-tech company with proprietary 3D cell culture automation—a critical bottleneck in modern drug discovery
- 100% H1B approval rate (3/3 in 2023) signals strong visa sponsorship and international talent strategy
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Mo:re
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.